通过NMR指导对接的高可靠性蛋白质 - 连接体复合模型使得早期的命中优化成为可能
Andrew Proudfoot1, Dirksen E Bussiere1, Andreas Lingel1,2
1Global Discovery Chemistry, Novartis Institutes for BioMedical Research , 5300 Chiron Way, Emeryville, California 94608, United States.
这项研究引入了一种基于结构的药物设计的新型NMR导向对接协议. 该方法成功生成了高质量的蛋白质-连接体复合模型,使药物片段的潜在优化成为可能.
科学领域:
- 生物化学
- 结构生物学
- 药物发现
背景情况:
- 基于结构的药物设计依赖于蛋白质 - 配体复合体的表征,通常是通过X射线结晶学.
- 对于动态蛋白质和弱结合剂,晶体学的成功是有限的,阻碍了药物优化.
- 这种限制限制了化学支架的多样性和药物发现的探索.
研究的目的:
- 开发一个强大的NMR限制导向对接协议,以生成高质量的蛋白质 - 连接体复合模型.
- 在药物发现中克服X射线结晶学的局限性.
- 为了使碎片的潜在优化达到更强大的结合剂.
主要方法:
- 使用一种新的NMR控制导向对接协议.
- 组合的高甲基标记蛋白与实验确定的分子间距离.
- 生成了全面的蛋白质 - 连接器距离限制以驱动对接并确定连接器构造.
主要成果:
- 成功生成了高质量的蛋白质-连接体复合体模型.
- 证明了NMR导向对接协议的实用性和性能.
- 实现了结晶学上难以处理的碎片对更强大的结合剂的潜在优化.
结论:
- 核磁共振抑制导向对接协议是基于结构的药物设计的强大工具.
- 这种方法克服了与X射线结晶学相关的难度.
- 能够加强化学空间的探索和优化新药候选物.
更多相关视频
10:33Development of Inhibitors of Protein-protein Interactions through REPLACE: Application to the Design and Development Non-ATP Competitive CDK Inhibitors
Published on: October 26, 2015
10:21Author Spotlight: Streamlining Protein Target Prediction and Validation via Molecular Docking and CETSA
Published on: February 23, 2024
相关概念视频
Ligand Binding Sites
Protein-ligand interactions are quite specific; even though numerous potential ligands surround a cellular protein at any given time, only a particular ligand can bind to that protein. Moreover, a ligand binds only to a dedicated area on the surface of the protein, known as the...
Ligand Binding Sites
The Equilibrium Binding Constant and Binding Strength
Conserved Binding Sites
Binding sites are often located in large pockets, and if their location on a protein’s surface is unknown, it can be predicted using various approaches. The energetic method computationally...
Protein-protein Interfaces
Induced-fit Model
Enzymes exhibit substrate specificity, meaning that they can only bind to certain substrates. This is mainly determined by the shape and chemical...
